Femirosal Dry Syrup (Femirolast Potassium)
Pemirolast Potassium 500mg
Syrup · Prescription medication
Hyundai Pharmaceutical Co., Ltd.
MFDS item code 201906898 · Notified 2019.09.28 · Insurance code 642004441
Treatment of perennial allergic rhinitis and bronchial asthma
This medication is used for bronchial asthma and perennial allergic rhinitis.
For bronchial asthma, for patients aged 11 years and older, the dosage is 2.0 g (10.0 mg of Femirolast Potassium) once, twice daily, after breakfast and before bedtime, dissolved and taken orally. For perennial allergic rhinitis, for patients aged 11 years and older, the dosage is 1.0 g (5.0 mg of Femirolast Potassium) once, twice daily, after breakfast and before bedtime, dissolved and taken orally.
For bronchial asthma: The usual dose for children is 0.2 mg/kg of pemirolast potassium per dose, administered orally after dissolving at the time of use, twice daily after breakfast and at bedtime. Adjust the dose as appropriate according to age and symptoms. The usual standard age-based doses are given below as single doses, administered orally after dissolving at the time of use, twice daily after breakfast and at bedtime. 1 year to under 5 years: 0.5g (equivalent to 2.5mg of pemirolast potassium) 5 years to under 11 years: 1.0g (equivalent to 5.0mg of pemirolast potassium) 11 years and older: 2.0g (equivalent to 10.0mg of pemirolast potassium) For perennial allergic rhinitis: The usual dose for children is 0.1 mg/kg of pemirolast potassium per dose, administered orally after dissolving at the time of use, twice daily after breakfast and at bedtime. Adjust the dose as appropriate according to age and symptoms. The usual standard age-based doses are given below as single doses, administered orally after dissolving at the time of use, twice daily after breakfast and at bedtime. 1 year to under 5 years: 0.25g (equivalent to 1.25mg of pemirolast potassium) 5 years to under 11 years: 0.5g (equivalent to 2.5mg of pemirolast potassium) 11 years and older: 1.0g (equivalent to 5.0mg of pemirolast potassium)
This medication should not be used in patients who are allergic to certain components, pregnant women, or babies under 1 year old. Patients with severely impaired liver or kidney function should be particularly cautious when using this medication. While taking this medication, side effects such as abdominal pain, elevated liver enzymes, drowsiness, and nausea may occur, so report any unusual symptoms immediately. If allergic reactions or symptoms such as cystitis appear, discontinue the medication and seek appropriate treatment. This medication is not a fast-acting drug for acute symptoms, so bronchodilators or corticosteroids may need to be used concurrently during severe symptoms. Patients undergoing long-term steroid treatment should follow their physician's guidance in gradually adjusting the steroid dosage when using this medication. Discontinuing this medication suddenly may worsen the original condition, so caution is advised. If there is no effectiveness, it is recommended not to continue long-term usage. When used in children, a caregiver should closely monitor and supervise. It is advisable to start taking this medication before the allergy season and continue until the season ends. Women who are pregnant or may become pregnant should not take this medication, and breastfeeding is also advised against. Safety for premature infants, newborns, and infants has not been established, so it is safer not to use it. Elderly patients may experience more side effects due to decreased bodily function, so precautions such as reducing dosages or dosing breaks should be taken. This medication can cause precipitation if mixed with other drugs, so it should not be combined with other medications. Store it in a cool, dry place out of reach of children, avoiding high temperatures or direct sunlight, and it's advisable to not use longer than 3 weeks after preparation. Additionally, to maintain quality, do not transfer to another container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a light-protected, airtight container at a temperature between 1°C and 30°C. Storing it this way helps maintain the medication's effectiveness.
White to pale yellow crystalline dry syrup
100 grams/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pemirolast Potassium 500mg
Syrup · Prescription medication
Hyundai Pharmaceutical Co., Ltd.
Pemirolast Potassium 1mg
Eye drops · Prescription medication
Korea Santen Pharmaceutical Co., Ltd.
Pemirolast Potassium
Prescription medication
Hyundai Pharmaceutical Co., Ltd.

Pemirolast Potassium 5mg
Tablet · Prescription medication
Hyundai Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.